Screening program raises awareness of valve disease

June 6, 2024

Heart valve disease is the next epidemic of cardiovascular disease, according to cardiologists.

To improve early diagnosis and get patients to specialized care quickly, the Centre for Valvular Heart Disease (CVHD) at the University of Ottawa Heart Institute launched an outreach program that delivers screening and cardiovascular risk factor checks in Ottawa and its surrounding communities.

The CVHD Mobile Screening Program is the first of its kind. During a 30- to 60-minute appointment, participants 65 years or older undergo a mini ultrasound of their heart, a cardiovascular risk factor screening and a finger poke blood test, followed by recommendations from a nurse. A cardiologist with expertise in echocardiography reviews all results. When valve disease is detected, participants are automatically referred to the CVHD for treatment and follow-up.

The CVHD Mobile Screening Program includes checks of blood pressure and other cardiovascular risk factors.

An important priority is to reach people most at risk for valve disease. With the collaboration of many community leaders, the program has screened individuals from various minority groups, underserved populations, rural communities, and Indigenous people.

From the program launch in May 2023 to March 2024, a total of 749 people were screened. Of those, 68 participants (9%) were diagnosed with valve disease and referred to the CVHD. Another 91 people (12.2%) were found to have other potentially significant heart issues, and sent to a primary care provider for a formal ultrasound. More than one-third of participants were referred to a primary care provider for management of uncontrolled cardiovascular risk factors such as diabetes, high blood pressure or high cholesterol.  

While the program is still early in its development, Heart Valve Voice Canada applauds this initiative to raise awareness of valve disease and improve access to care.